| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.20e-05 | 11 | 85 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | EGR2 EGR3 NFIC PLSCR2 ZNF227 RFX4 TFAP2B TFAP2C GLIS1 NOTCH2 SMAD4 | 2.50e-05 | 560 | 85 | 11 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | EGR2 EGR3 NFIC PLSCR2 ZNF227 RFX4 TFAP2B TFAP2C GLIS1 NOTCH2 SMAD4 | 2.75e-05 | 566 | 85 | 11 | GO:0001216 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.02e-04 | 109 | 85 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 1.80e-04 | 26 | 85 | 3 | GO:0070412 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | TCF7 FOXD4L1 EGR2 EGR3 NFIC GLI3 TRPS1 PLSCR2 IRX1 ZNF227 RFX4 TFAP2B TFAP2C GLIS1 NOTCH2 SMAD4 | 2.69e-04 | 1412 | 85 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | protein domain specific binding | NCOR1 ZNF106 KCNA1 EGR2 TJP1 TRPS1 PLSCR2 PLG SHROOM2 ATP2B2 ATP2B3 ATP2B4 | 3.22e-04 | 875 | 85 | 12 | GO:0019904 |
| GeneOntologyMolecularFunction | calmodulin binding | 4.48e-04 | 230 | 85 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 4.80e-04 | 36 | 85 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 4.80e-04 | 36 | 85 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | SMAD binding | 4.98e-04 | 86 | 85 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TCF7 FOXD4L1 EGR2 EGR3 NFIC GLI3 IRX1 ZNF227 RFX4 TFAP2B TFAP2C GLIS1 NOTCH2 SMAD4 | 9.01e-04 | 1271 | 85 | 14 | GO:0000987 |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 9.81e-04 | 178 | 85 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NCOR1 TCF7 FOXD4L1 EGR2 EGR3 NFIC GLI3 TRPS1 IRX1 ZNF227 RFX4 TFAP2B TFAP2C GLIS1 SMAD4 | 1.17e-03 | 1459 | 85 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.73e-03 | 120 | 85 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 1.81e-03 | 15 | 85 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TCF7 FOXD4L1 EGR2 EGR3 NFIC GLI3 IRX1 ZNF227 RFX4 TFAP2B TFAP2C GLIS1 SMAD4 | 2.23e-03 | 1244 | 85 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | water channel activity | 2.34e-03 | 17 | 85 | 2 | GO:0015250 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 2.34e-03 | 17 | 85 | 2 | GO:0070411 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.35e-03 | 62 | 85 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | kinase binding | PTK2B EGFR PSG2 RPTOR MAML1 PLD2 PLG STK11IP ATP2B4 ARHGAP33 NCK2 | 2.65e-03 | 969 | 85 | 11 | GO:0019900 |
| GeneOntologyMolecularFunction | transporter activity | PTK2B AQP12A KCNA1 PSG2 RALBP1 PLSCR2 OTOP3 SHROOM2 ATP2B2 ATP2B3 ATP2B4 ABCA8 AQP12B | 3.04e-03 | 1289 | 85 | 13 | GO:0005215 |
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.24e-03 | 20 | 85 | 2 | GO:0061665 | |
| GeneOntologyMolecularFunction | water transmembrane transporter activity | 3.24e-03 | 20 | 85 | 2 | GO:0005372 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | PTK2B COL18A1 TCF7 EGFR PSG2 EGR3 TJP1 RTL1 GLI3 LAMA5 IRX1 PLG ECM1 TERT TFAP2B ATP2B4 TFAP2C NOTCH2 SMAD4 | 9.59e-08 | 1125 | 84 | 19 | GO:0035239 |
| GeneOntologyBiologicalProcess | tube development | PTK2B COL18A1 TCF7 PLOD3 EGFR PSG2 EGR3 TJP1 RTL1 GLI3 LAMA5 IRX1 PLG PDGFC ECM1 TERT TFAP2B ATP2B4 TFAP2C NOTCH2 SMAD4 | 1.35e-07 | 1402 | 84 | 21 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 2.08e-07 | 103 | 84 | 7 | GO:2000628 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 5.59e-07 | 119 | 84 | 7 | GO:0010586 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | PTK2B NCOR1 COL18A1 KMT2C EGFR EGR3 TJP1 BICRA ACAN RPTOR GLI3 PDGFC ECM1 TERT TFAP2B NOTCH2 NCK2 SMAD4 | 1.11e-06 | 1190 | 84 | 18 | GO:0008284 |
| GeneOntologyBiologicalProcess | circulatory system development | PTK2B COL18A1 EGFR PSG2 EGR2 EGR3 TJP1 RTL1 ACAN GLI3 MAML1 SLITRK5 PLG ECM1 TERT TFAP2B ATP2B4 NOTCH2 SMAD4 | 4.09e-06 | 1442 | 84 | 19 | GO:0072359 |
| GeneOntologyBiologicalProcess | nephron tubule development | 5.81e-06 | 110 | 84 | 6 | GO:0072080 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | PTK2B COL18A1 PHLDB1 PSG2 EGR2 EGR3 TJP1 RTL1 GLI3 IRX1 PLG ECM1 TERT ATP2B2 ATP2B4 TFAP2C MEGF11 NOTCH2 SMAD4 | 6.14e-06 | 1483 | 84 | 19 | GO:0048646 |
| GeneOntologyBiologicalProcess | regulation of cell development | PTK2B TCF7 EGFR PSG2 EGR2 EGR3 DROSHA AXL ACAN RPTOR GLI3 SMURF1 TMEM131L TERT NOTCH2 SMAD4 | 7.51e-06 | 1095 | 84 | 16 | GO:0060284 |
| GeneOntologyBiologicalProcess | renal tubule development | 7.90e-06 | 116 | 84 | 6 | GO:0061326 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | COL18A1 TCF7 PLOD3 EGFR PSG2 NFIC ACAN GLI3 LAMA5 IRX1 PDGFC SHROOM2 ATP2B2 TFAP2C MEGF11 NOTCH2 SMAD4 | 1.17e-05 | 1269 | 84 | 17 | GO:0009887 |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 1.20e-05 | 73 | 84 | 5 | GO:2000630 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 1.39e-05 | 128 | 84 | 6 | GO:0072009 | |
| GeneOntologyBiologicalProcess | epithelium development | NCOR1 COL18A1 TCF7 PLOD3 EGFR PSG2 TJP1 RPTOR GLI3 TRPS1 LAMA5 KAZN IRX1 ATP2B2 TFAP2B TFAP2C NOTCH2 SMAD4 | 2.07e-05 | 1469 | 84 | 18 | GO:0060429 |
| GeneOntologyBiologicalProcess | skin development | 2.09e-05 | 373 | 84 | 9 | GO:0043588 | |
| GeneOntologyBiologicalProcess | blood vessel development | PTK2B COL18A1 PSG2 EGR2 EGR3 TJP1 RTL1 GLI3 PLG ECM1 TERT TFAP2B ATP2B4 NOTCH2 | 2.15e-05 | 929 | 84 | 14 | GO:0001568 |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 2.25e-05 | 83 | 84 | 5 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 2.38e-05 | 84 | 84 | 5 | GO:0061614 | |
| GeneOntologyBiologicalProcess | molting cycle | 3.41e-05 | 150 | 84 | 6 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 3.41e-05 | 150 | 84 | 6 | GO:0042633 | |
| GeneOntologyBiologicalProcess | vasculature development | PTK2B COL18A1 PSG2 EGR2 EGR3 TJP1 RTL1 GLI3 PLG ECM1 TERT TFAP2B ATP2B4 NOTCH2 | 3.42e-05 | 969 | 84 | 14 | GO:0001944 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | EGFR PSG2 EGR2 EGR3 NEK5 AXL ACAN RPTOR GLI3 MAML1 SMURF1 NOCT TERT NOTCH2 SMAD4 | 5.14e-05 | 1141 | 84 | 15 | GO:0045597 |
| GeneOntologyBiologicalProcess | kidney epithelium development | 5.24e-05 | 162 | 84 | 6 | GO:0072073 | |
| GeneOntologyBiologicalProcess | embryo development | NCOR1 COL18A1 PHLDB1 TCF7 PLOD3 EGFR TJP1 RTL1 GLI3 LAMA5 IRX1 NOCT PLG ATP2B2 TFAP2C NOTCH2 SMAD4 | 5.71e-05 | 1437 | 84 | 17 | GO:0009790 |
| GeneOntologyBiologicalProcess | camera-type eye development | 5.89e-05 | 426 | 84 | 9 | GO:0043010 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 6.01e-05 | 166 | 84 | 6 | GO:0098773 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 6.21e-05 | 429 | 84 | 9 | GO:1902105 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 6.76e-05 | 540 | 84 | 10 | GO:1903706 | |
| GeneOntologyBiologicalProcess | nephron development | 7.80e-05 | 174 | 84 | 6 | GO:0072006 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | PTK2B COL18A1 PLOD3 HECW1 EGFR EGR2 GLI3 SMURF1 SLITRK5 LAMA5 SHROOM2 ATP2B2 NOTCH2 ARHGAP33 SMAD4 | 8.59e-05 | 1194 | 84 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | central nervous system development | NCOR1 KCNA1 EGFR EGR2 IL1RAPL2 AXL ACAN GLI3 SLITRK5 PDGFC SHROOM2 RFX4 ATP2B2 ATP2B4 TFAP2C | 8.83e-05 | 1197 | 84 | 15 | GO:0007417 |
| GeneOntologyBiologicalProcess | gland morphogenesis | 8.84e-05 | 178 | 84 | 6 | GO:0022612 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | PTK2B COL18A1 EGFR PSG2 TJP1 ACAN PRSS56 LAMA5 PLD2 PLG PDGFC ECM1 TERT ATP2B4 SMURF2 | 1.01e-04 | 1211 | 84 | 15 | GO:0030334 |
| GeneOntologyBiologicalProcess | cell activation | PTK2B NCOR1 TCF7 EGFR PSG2 EGR3 DROSHA AXL GLI3 TMEM131L PLSCR2 PLD2 NOTCH2 NCK2 SMAD4 PEAR1 | 1.01e-04 | 1356 | 84 | 16 | GO:0001775 |
| GeneOntologyBiologicalProcess | epidermis development | 1.07e-04 | 461 | 84 | 9 | GO:0008544 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 1.12e-04 | 61 | 84 | 4 | GO:1902895 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | PTK2B COL18A1 PSG2 EGR3 TJP1 RTL1 PLG ECM1 TERT TFAP2B ATP2B4 NOTCH2 | 1.13e-04 | 817 | 84 | 12 | GO:0048514 |
| GeneOntologyBiologicalProcess | angiogenesis | PTK2B COL18A1 PSG2 EGR3 TJP1 RTL1 PLG ECM1 TERT ATP2B4 NOTCH2 | 1.37e-04 | 708 | 84 | 11 | GO:0001525 |
| GeneOntologyBiologicalProcess | eye development | 1.46e-04 | 480 | 84 | 9 | GO:0001654 | |
| GeneOntologyBiologicalProcess | hair follicle development | 1.47e-04 | 123 | 84 | 5 | GO:0001942 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 1.52e-04 | 596 | 84 | 10 | GO:0001701 | |
| GeneOntologyBiologicalProcess | visual system development | 1.53e-04 | 483 | 84 | 9 | GO:0150063 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.65e-04 | 382 | 84 | 8 | GO:0043491 | |
| GeneOntologyBiologicalProcess | molting cycle process | 1.65e-04 | 126 | 84 | 5 | GO:0022404 | |
| GeneOntologyBiologicalProcess | hair cycle process | 1.65e-04 | 126 | 84 | 5 | GO:0022405 | |
| GeneOntologyBiologicalProcess | forebrain development | 1.67e-04 | 489 | 84 | 9 | GO:0030900 | |
| GeneOntologyBiologicalProcess | sensory system development | 1.73e-04 | 491 | 84 | 9 | GO:0048880 | |
| GeneOntologyBiologicalProcess | brain development | NCOR1 KCNA1 EGFR EGR2 AXL GLI3 SLITRK5 SHROOM2 RFX4 ATP2B2 ATP2B4 TFAP2C | 1.80e-04 | 859 | 84 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | regulation of cell motility | PTK2B COL18A1 EGFR PSG2 TJP1 ACAN PRSS56 LAMA5 PLD2 PLG PDGFC ECM1 TERT ATP2B4 SMURF2 | 1.85e-04 | 1280 | 84 | 15 | GO:2000145 |
| GeneOntologyBiologicalProcess | neuron projection development | PTK2B KCNA1 HECW1 EGFR EGR2 GLI3 SMURF1 SLITRK5 LAMA5 PLD2 ATP2B2 NOTCH2 ARHGAP33 NCK2 SMAD4 | 1.93e-04 | 1285 | 84 | 15 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 2.21e-04 | 29 | 84 | 3 | GO:1903779 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 2.49e-04 | 516 | 84 | 9 | GO:0016055 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | PTK2B COL18A1 EGFR PSG2 TJP1 ACAN PRSS56 LAMA5 PLD2 PLG PDGFC ECM1 TERT ATP2B4 SMURF2 | 2.74e-04 | 1327 | 84 | 15 | GO:0040012 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | NCOR1 TCF7 NFIC GLI3 TRPS1 IRX1 TFAP2B SMURF2 TFAP2C GLIS1 NOTCH2 NCK2 SMAD4 | 3.19e-04 | 1053 | 84 | 13 | GO:0000122 |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 3.34e-04 | 537 | 84 | 9 | GO:0030098 | |
| GeneOntologyBiologicalProcess | head development | NCOR1 KCNA1 EGFR EGR2 AXL GLI3 SLITRK5 SHROOM2 RFX4 ATP2B2 ATP2B4 TFAP2C | 3.35e-04 | 919 | 84 | 12 | GO:0060322 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF, modulating synaptic transmission | 3.40e-04 | 7 | 84 | 2 | GO:0099183 | |
| GeneOntologyBiologicalProcess | response to hydrostatic pressure | 3.40e-04 | 7 | 84 | 2 | GO:0051599 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | PTK2B NCOR1 TCF7 PSG2 EGR3 DROSHA AXL RPTOR GLI3 TMEM131L NOTCH2 | 3.49e-04 | 789 | 84 | 11 | GO:0002521 |
| GeneOntologyBiologicalProcess | telencephalon development | 4.12e-04 | 332 | 84 | 7 | GO:0021537 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 4.27e-04 | 334 | 84 | 7 | GO:0051896 | |
| GeneOntologyBiologicalProcess | nephron tubule morphogenesis | 4.41e-04 | 87 | 84 | 4 | GO:0072078 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | KMT2C EGFR EGR2 EGR3 NFIC GLI3 MAML1 ZNF227 RFX4 TFAP2B TFAP2C GLIS1 NOTCH2 NCK2 SMAD4 | 4.48e-04 | 1390 | 84 | 15 | GO:0045944 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF | 4.52e-04 | 8 | 84 | 2 | GO:0099191 | |
| GeneOntologyBiologicalProcess | signal complex assembly | 4.52e-04 | 8 | 84 | 2 | GO:0007172 | |
| GeneOntologyBiologicalProcess | ossification | 4.65e-04 | 562 | 84 | 9 | GO:0001503 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 4.69e-04 | 158 | 84 | 5 | GO:0045446 | |
| GeneOntologyBiologicalProcess | nephron epithelium morphogenesis | 4.80e-04 | 89 | 84 | 4 | GO:0072088 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | 4.93e-04 | 691 | 84 | 10 | GO:0030335 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 5.09e-04 | 344 | 84 | 7 | GO:0060070 | |
| GeneOntologyBiologicalProcess | nephron morphogenesis | 5.23e-04 | 91 | 84 | 4 | GO:0072028 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 5.62e-04 | 577 | 84 | 9 | GO:0001667 | |
| GeneOntologyBiologicalProcess | renal tubule morphogenesis | 5.67e-04 | 93 | 84 | 4 | GO:0061333 | |
| GeneOntologyBiologicalProcess | cardiac conduction system development | 5.77e-04 | 40 | 84 | 3 | GO:0003161 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 5.79e-04 | 9 | 84 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | hindgut morphogenesis | 5.79e-04 | 9 | 84 | 2 | GO:0007442 | |
| GeneOntologyBiologicalProcess | metanephros development | 6.15e-04 | 95 | 84 | 4 | GO:0001656 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 7.05e-04 | 262 | 84 | 6 | GO:0048771 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | 7.15e-04 | 725 | 84 | 10 | GO:2000147 | |
| GeneOntologyBiologicalProcess | hindgut development | 7.22e-04 | 10 | 84 | 2 | GO:0061525 | |
| GeneOntologyBiologicalProcess | marginal zone B cell differentiation | 7.22e-04 | 10 | 84 | 2 | GO:0002315 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 7.58e-04 | 368 | 84 | 7 | GO:0030111 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 7.62e-04 | 266 | 84 | 6 | GO:0045619 | |
| GeneOntologyBiologicalProcess | neuron development | PTK2B KCNA1 HECW1 EGFR EGR2 GLI3 SMURF1 SLITRK5 LAMA5 PLD2 ATP2B2 NOTCH2 ARHGAP33 NCK2 SMAD4 | 7.64e-04 | 1463 | 84 | 15 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of neuroblast proliferation | 7.65e-04 | 44 | 84 | 3 | GO:0002052 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation | 7.70e-04 | 603 | 84 | 9 | GO:0050673 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell proliferation | 8.24e-04 | 270 | 84 | 6 | GO:0050679 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | 8.54e-04 | 742 | 84 | 10 | GO:0040017 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 8.64e-04 | 104 | 84 | 4 | GO:0007405 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 8.74e-04 | 614 | 84 | 9 | GO:0010720 | |
| GeneOntologyBiologicalProcess | endothelium development | 8.90e-04 | 182 | 84 | 5 | GO:0003158 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HECW1 EGR2 GLI3 SMURF1 SLITRK5 LAMA5 ATP2B2 NOTCH2 ARHGAP33 SMAD4 | 9.08e-04 | 748 | 84 | 10 | GO:0048667 |
| GeneOntologyBiologicalProcess | leukocyte activation | PTK2B NCOR1 TCF7 PSG2 EGR3 DROSHA AXL GLI3 TMEM131L PLSCR2 PLD2 NOTCH2 NCK2 | 9.74e-04 | 1186 | 84 | 13 | GO:0045321 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | PTK2B ZNF106 EGFR PSG2 AXL TRPS1 SMURF1 PDGFC TFAP2B SMURF2 NOTCH2 NCK2 SMAD4 | 9.74e-04 | 1186 | 84 | 13 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of cell activation | 9.84e-04 | 756 | 84 | 10 | GO:0050865 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 1.05e-03 | 12 | 84 | 2 | GO:0070831 | |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 1.09e-03 | 285 | 84 | 6 | GO:0060828 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOR1 TCF7 PLOD3 EGFR TJP1 RTL1 GLI3 PLG TFAP2C NOTCH2 SMAD4 | 1.10e-03 | 906 | 84 | 11 | GO:0043009 |
| GeneOntologyBiologicalProcess | kidney morphogenesis | 1.10e-03 | 111 | 84 | 4 | GO:0060993 | |
| GeneOntologyBiologicalProcess | negative regulation of ossification | 1.11e-03 | 50 | 84 | 3 | GO:0030279 | |
| GeneOntologyCellularComponent | basal part of cell | 1.40e-04 | 378 | 84 | 8 | GO:0045178 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 3.05e-04 | 320 | 84 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | glutamatergic synapse | PTK2B KCNA1 IL1RAPL2 DROSHA ACAN LAMA5 PLG ATP2B2 ATP2B3 ATP2B4 ARHGAP33 | 4.18e-04 | 817 | 84 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | basal plasma membrane | 5.58e-04 | 354 | 84 | 7 | GO:0009925 | |
| HumanPheno | Short finger | 2.06e-06 | 325 | 26 | 10 | HP:0009381 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 6.08e-06 | 366 | 26 | 10 | HP:0006265 | |
| HumanPheno | Short phalanx of finger | 1.14e-05 | 306 | 26 | 9 | HP:0009803 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 1.60e-05 | 319 | 26 | 9 | HP:0009767 | |
| HumanPheno | Abnormal morphology of bones of the lower limbs | 2.16e-05 | 422 | 26 | 10 | HP:0040066 | |
| HumanPheno | Brachydactyly (hand) | 2.55e-05 | 430 | 26 | 10 | HP:0100667 | |
| HumanPheno | Abnormal long bone morphology | PHLDB1 KCNA1 PLOD3 RTL1 BICRA ACAN GLI3 TRPS1 LAMA5 CILK1 TERT NOTCH2 SMAD4 | 6.02e-05 | 821 | 26 | 13 | HP:0011314 |
| HumanPheno | Abnormality of the calf | 7.04e-05 | 384 | 26 | 9 | HP:0002981 | |
| HumanPheno | Thick eyebrow | 9.66e-05 | 154 | 26 | 6 | HP:0000574 | |
| HumanPheno | Bowing of the long bones | 1.17e-04 | 316 | 26 | 8 | HP:0006487 | |
| HumanPheno | Abnormal nail morphology | 1.23e-04 | 516 | 26 | 10 | HP:0001597 | |
| HumanPheno | Abnormality of the tubular bones | PHLDB1 KCNA1 RTL1 BICRA ACAN GLI3 TRPS1 LAMA5 CILK1 NOTCH2 SMAD4 | 1.30e-04 | 632 | 26 | 11 | HP:0100713 |
| HumanPheno | Abnormality of the long tubular bones | PHLDB1 KCNA1 RTL1 BICRA ACAN GLI3 TRPS1 LAMA5 CILK1 NOTCH2 SMAD4 | 1.30e-04 | 632 | 26 | 11 | HP:0100714 |
| HumanPheno | Anomaly of the limb diaphyses | 1.34e-04 | 322 | 26 | 8 | HP:0006504 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 1.76e-04 | 538 | 26 | 10 | HP:0005927 | |
| HumanPheno | Bowing of the legs | 2.05e-04 | 254 | 26 | 7 | HP:0002979 | |
| HumanPheno | Abnormal diaphysis morphology | 2.08e-04 | 343 | 26 | 8 | HP:0000940 | |
| HumanPheno | Abnormal metaphysis morphology | 2.12e-04 | 344 | 26 | 8 | HP:0000944 | |
| HumanPheno | Brachydactyly | KCNA1 RTL1 BICRA ACAN GLI3 TRPS1 LAMA5 CILK1 TFAP2B NOTCH2 SMAD4 | 2.22e-04 | 670 | 26 | 11 | HP:0001156 |
| HumanPheno | Short digit | KCNA1 RTL1 BICRA ACAN GLI3 TRPS1 LAMA5 CILK1 TFAP2B NOTCH2 SMAD4 | 2.28e-04 | 672 | 26 | 11 | HP:0011927 |
| HumanPheno | Abnormal form of the vertebral bodies | 2.30e-04 | 348 | 26 | 8 | HP:0003312 | |
| HumanPheno | Abnormal 3rd finger morphology | 2.84e-04 | 26 | 26 | 3 | HP:0004150 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | 2.93e-04 | 572 | 26 | 10 | HP:0006496 | |
| HumanPheno | Short tibia | 3.18e-04 | 27 | 26 | 3 | HP:0005736 | |
| HumanPheno | Platyspondyly | 3.44e-04 | 124 | 26 | 5 | HP:0000926 | |
| HumanPheno | Abnormal midface morphology | COL18A1 KMT2C PLOD3 RTL1 BICRA ACAN CILK1 TERT TFAP2B NOTCH2 SMAD4 | 3.47e-04 | 704 | 26 | 11 | HP:0000309 |
| HumanPheno | Short thumb | 3.84e-04 | 127 | 26 | 5 | HP:0009778 | |
| HumanPheno | Abnormal eyelash morphology | 4.08e-04 | 284 | 26 | 7 | HP:0000499 | |
| HumanPheno | Abnormal femoral neck/head morphology | 4.16e-04 | 201 | 26 | 6 | HP:0003366 | |
| HumanPheno | Abnormal upper limb bone morphology | 4.18e-04 | 484 | 26 | 9 | HP:0040070 | |
| HumanPheno | Abnormality of thumb phalanx | 4.62e-04 | 205 | 26 | 6 | HP:0009602 | |
| HumanPheno | Macrocephaly | 4.66e-04 | 491 | 26 | 9 | HP:0000256 | |
| HumanPheno | Hypoplastic iliac wing | 4.83e-04 | 31 | 26 | 3 | HP:0002866 | |
| HumanPheno | Abnormal lower limb bone morphology | PHLDB1 KCNA1 PLOD3 RTL1 ACAN GLI3 TRPS1 LAMA5 CILK1 TFAP2B NOTCH2 SMAD4 | 5.07e-04 | 866 | 26 | 12 | HP:0040069 |
| HumanPheno | Mesoaxial foot polydactyly | 5.18e-04 | 7 | 26 | 2 | HP:0010112 | |
| HumanPheno | Abnormal finger phalanx morphology | KCNA1 PLOD3 RTL1 BICRA ACAN GLI3 TRPS1 LAMA5 CILK1 TFAP2B NOTCH2 | 5.28e-04 | 738 | 26 | 11 | HP:0005918 |
| HumanPheno | Increased head circumference | 5.34e-04 | 500 | 26 | 9 | HP:0040194 | |
| HumanPheno | Aplasia/Hypoplasia of the tibia | 5.82e-04 | 33 | 26 | 3 | HP:0005772 | |
| HumanPheno | Triangular shaped phalanges of the hand | 5.82e-04 | 214 | 26 | 6 | HP:0009774 | |
| HumanPheno | Abnormal femur morphology | 6.17e-04 | 304 | 26 | 7 | HP:0002823 | |
| HumanPheno | Bowed forearm bones | 7.54e-04 | 36 | 26 | 3 | HP:0003956 | |
| HumanPheno | Broad phalanx | 7.77e-04 | 148 | 26 | 5 | HP:0006009 | |
| HumanPheno | Broad phalanges of the hand | 7.77e-04 | 148 | 26 | 5 | HP:0009768 | |
| HumanPheno | Supernumerary tooth | 8.16e-04 | 85 | 26 | 4 | HP:0011069 | |
| HumanPheno | Periodontitis | 8.18e-04 | 37 | 26 | 3 | HP:0000704 | |
| HumanPheno | Short phalanx of the thumb | 8.18e-04 | 37 | 26 | 3 | HP:0009660 | |
| HumanPheno | Aplasia/Hypoplasia of the thumb | 8.26e-04 | 150 | 26 | 5 | HP:0009601 | |
| HumanPheno | Hydrocephalus | 8.39e-04 | 421 | 26 | 8 | HP:0000238 | |
| HumanPheno | Abnormality of the thigh | 8.72e-04 | 322 | 26 | 7 | HP:0001439 | |
| HumanPheno | Natal tooth | 8.85e-04 | 38 | 26 | 3 | HP:0000695 | |
| HumanPheno | Broad finger | 9.31e-04 | 154 | 26 | 5 | HP:0001500 | |
| HumanPheno | Abnormal finger morphology | KMT2C KCNA1 PLOD3 RTL1 BICRA ACAN GLI3 TRPS1 LRRC56 LAMA5 CILK1 TERT TFAP2B NOTCH2 SMAD4 | 9.94e-04 | 1385 | 26 | 15 | HP:0001167 |
| HumanPheno | Broad long bones | 1.02e-03 | 157 | 26 | 5 | HP:0005622 | |
| HumanPheno | Hypoplastic facial bones | 1.03e-03 | 331 | 26 | 7 | HP:0002692 | |
| HumanPheno | Aplasia/Hypoplasia of facial bones | 1.05e-03 | 332 | 26 | 7 | HP:0034261 | |
| HumanPheno | Abnormal morphology of bones of the upper limbs | 1.06e-03 | 436 | 26 | 8 | HP:0040065 | |
| HumanPheno | Abnormal hand morphology | KCNA1 PLOD3 EGR2 RTL1 BICRA ACAN GLI3 TRPS1 LAMA5 CILK1 TFAP2B NOTCH2 SMAD4 | 1.07e-03 | 1082 | 26 | 13 | HP:0005922 |
| HumanPheno | Abnormal femoral head morphology | 1.10e-03 | 92 | 26 | 4 | HP:0003368 | |
| HumanPheno | Chin with horizontal crease | 1.10e-03 | 10 | 26 | 2 | HP:0011823 | |
| HumanPheno | Hypoplasia of the epiglottis | 1.10e-03 | 10 | 26 | 2 | HP:0005349 | |
| HumanPheno | Abnormal eyebrow morphology | TYRP1 COL18A1 KMT2C EGFR BICRA TRPS1 TERT TFAP2B NOTCH2 SMAD4 | 1.11e-03 | 674 | 26 | 10 | HP:0000534 |
| HumanPheno | Abnormal breast morphology | 1.14e-03 | 441 | 26 | 8 | HP:0031093 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 1.19e-03 | 94 | 26 | 4 | HP:0006500 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | KCNA1 RTL1 BICRA ACAN GLI3 TRPS1 LAMA5 CILK1 TFAP2B NOTCH2 SMAD4 | 1.22e-03 | 813 | 26 | 11 | HP:0009815 |
| HumanPheno | Abnormality of the breast | 1.25e-03 | 447 | 26 | 8 | HP:0000769 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | TYRP1 NCOR1 KMT2C ZSWIM8 PLOD3 EGFR EGR2 RTL1 BICRA ACAN GLI3 TRPS1 MAML1 LAMA5 CILK1 IRX1 PDGFC RFX4 TFAP2B NOTCH2 | 1.80e-05 | 1269 | 79 | 20 | MP:0011111 |
| MousePheno | perinatal lethality, complete penetrance | TYRP1 KMT2C ZSWIM8 PLOD3 EGFR RTL1 ACAN GLI3 TRPS1 CILK1 IRX1 RFX4 TFAP2B NOTCH2 | 3.97e-05 | 712 | 79 | 14 | MP:0011089 |
| MousePheno | small lung | 4.64e-05 | 115 | 79 | 6 | MP:0003641 | |
| MousePheno | abnormal basement membrane morphology | 7.40e-05 | 40 | 79 | 4 | MP:0004272 | |
| MousePheno | abnormal lung morphology | ZSWIM8 PLOD3 EGFR ACAN GLI3 TRPS1 RGPD1 LRRC56 LAMA5 CILK1 IRX1 PLG TFAP2B SMAD4 | 8.88e-05 | 767 | 79 | 14 | MP:0001175 |
| MousePheno | abnormal Reichert's membrane morphology | 9.23e-05 | 16 | 79 | 3 | MP:0003954 | |
| MousePheno | abnormal placenta labyrinth morphology | 1.11e-04 | 194 | 79 | 7 | MP:0001716 | |
| MousePheno | respiratory distress | 1.52e-04 | 204 | 79 | 7 | MP:0001954 | |
| MousePheno | perinatal lethality | TYRP1 KMT2C ZSWIM8 PLOD3 EGFR EGR2 RTL1 ACAN GLI3 TRPS1 CILK1 IRX1 PDGFC RFX4 TFAP2B NOTCH2 BAHCC1 | 1.55e-04 | 1130 | 79 | 17 | MP:0002081 |
| MousePheno | short nasal septum | 1.88e-04 | 4 | 79 | 2 | MP:0030203 | |
| Domain | ATP_Ca_trans_C | 3.37e-07 | 4 | 83 | 3 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 3.37e-07 | 4 | 83 | 3 | PF12424 | |
| Domain | P-type_ATPase_IIB | 3.37e-07 | 4 | 83 | 3 | IPR006408 | |
| Domain | Aquaporin_12 | 1.95e-05 | 2 | 83 | 2 | IPR023265 | |
| Domain | - | 4.55e-05 | 16 | 83 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 4.55e-05 | 16 | 83 | 3 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 5.50e-05 | 17 | 83 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 5.50e-05 | 17 | 83 | 3 | PF00689 | |
| Domain | WW | 5.59e-05 | 47 | 83 | 4 | PF00397 | |
| Domain | DUF3446 | 5.84e-05 | 3 | 83 | 2 | IPR021849 | |
| Domain | Aquaporin_11/12 | 5.84e-05 | 3 | 83 | 2 | IPR016697 | |
| Domain | DUF3446 | 5.84e-05 | 3 | 83 | 2 | PF11928 | |
| Domain | WW | 6.08e-05 | 48 | 83 | 4 | SM00456 | |
| Domain | Cation_ATPase_N | 6.58e-05 | 18 | 83 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 6.58e-05 | 18 | 83 | 3 | SM00831 | |
| Domain | WW_DOMAIN_2 | 7.73e-05 | 51 | 83 | 4 | PS50020 | |
| Domain | WW_DOMAIN_1 | 7.73e-05 | 51 | 83 | 4 | PS01159 | |
| Domain | ATPase_P-typ_cation-transptr_N | 7.79e-05 | 19 | 83 | 3 | IPR004014 | |
| Domain | WW_dom | 8.34e-05 | 52 | 83 | 4 | IPR001202 | |
| Domain | TF_AP2 | 1.93e-04 | 5 | 83 | 2 | IPR004979 | |
| Domain | TF_AP2_C | 1.93e-04 | 5 | 83 | 2 | IPR013854 | |
| Domain | TF_AP-2 | 1.93e-04 | 5 | 83 | 2 | PF03299 | |
| Domain | HECT | 2.29e-04 | 27 | 83 | 3 | PF00632 | |
| Domain | HECTc | 2.29e-04 | 27 | 83 | 3 | SM00119 | |
| Domain | HECT_dom | 2.29e-04 | 27 | 83 | 3 | IPR000569 | |
| Domain | HECT | 2.29e-04 | 27 | 83 | 3 | PS50237 | |
| Domain | Laminin_EGF | 5.00e-04 | 35 | 83 | 3 | PF00053 | |
| Domain | EGF_Lam | 5.00e-04 | 35 | 83 | 3 | SM00180 | |
| Domain | ATPase_P-typ_cyto_domN | 5.00e-04 | 35 | 83 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 5.44e-04 | 36 | 83 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 5.44e-04 | 36 | 83 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 5.44e-04 | 36 | 83 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 5.90e-04 | 37 | 83 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 5.90e-04 | 37 | 83 | 3 | PF00122 | |
| Domain | Laminin_EGF | 6.38e-04 | 38 | 83 | 3 | IPR002049 | |
| Domain | Hydrolase_3 | 8.58e-04 | 10 | 83 | 2 | PF08282 | |
| Domain | BAH | 1.05e-03 | 11 | 83 | 2 | SM00439 | |
| Domain | BAH | 1.05e-03 | 11 | 83 | 2 | PF01426 | |
| Domain | BAH | 1.05e-03 | 11 | 83 | 2 | PS51038 | |
| Domain | BAH_dom | 1.05e-03 | 11 | 83 | 2 | IPR001025 | |
| Domain | MAD_homology1_Dwarfin-type | 1.25e-03 | 12 | 83 | 2 | IPR003619 | |
| Domain | DWA | 1.25e-03 | 12 | 83 | 2 | SM00523 | |
| Domain | MH1 | 1.25e-03 | 12 | 83 | 2 | PF03165 | |
| Domain | MIP | 1.72e-03 | 14 | 83 | 2 | PS00221 | |
| Domain | MIP | 1.72e-03 | 14 | 83 | 2 | PF00230 | |
| Domain | MIP | 1.97e-03 | 15 | 83 | 2 | IPR000425 | |
| Domain | - | 1.97e-03 | 15 | 83 | 2 | 1.20.1080.10 | |
| Domain | Aquaporin-like | 1.97e-03 | 15 | 83 | 2 | IPR023271 | |
| Domain | EMI_domain | 2.25e-03 | 16 | 83 | 2 | IPR011489 | |
| Domain | EMI | 2.54e-03 | 17 | 83 | 2 | PS51041 | |
| Domain | RhoGAP | 2.65e-03 | 62 | 83 | 3 | SM00324 | |
| Domain | SH3 | 2.76e-03 | 216 | 83 | 5 | SM00326 | |
| Domain | SH3 | 2.76e-03 | 216 | 83 | 5 | PS50002 | |
| Domain | RhoGAP | 2.77e-03 | 63 | 83 | 3 | PF00620 | |
| Domain | RHOGAP | 2.90e-03 | 64 | 83 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 2.90e-03 | 64 | 83 | 3 | IPR000198 | |
| Domain | - | 2.90e-03 | 64 | 83 | 3 | 1.10.555.10 | |
| Domain | SH3_domain | 2.99e-03 | 220 | 83 | 5 | IPR001452 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.34e-03 | 138 | 83 | 4 | IPR001245 | |
| Domain | GUANYLATE_KINASE_2 | 4.65e-03 | 23 | 83 | 2 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 4.65e-03 | 23 | 83 | 2 | PS00856 | |
| Domain | HAD-like_dom | 5.25e-03 | 79 | 83 | 3 | IPR023214 | |
| Domain | Guanylate_kin | 5.92e-03 | 26 | 83 | 2 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 5.92e-03 | 26 | 83 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 5.92e-03 | 26 | 83 | 2 | IPR008144 | |
| Domain | GuKc | 5.92e-03 | 26 | 83 | 2 | SM00072 | |
| Domain | SH3_1 | 6.15e-03 | 164 | 83 | 4 | PF00018 | |
| Domain | hEGF | 6.84e-03 | 28 | 83 | 2 | PF12661 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 8.29e-07 | 74 | 62 | 6 | M39857 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.30e-05 | 11 | 62 | 3 | MM15510 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.73e-05 | 12 | 62 | 3 | M27765 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.73e-05 | 12 | 62 | 3 | M27326 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 2.03e-05 | 76 | 62 | 5 | MM15520 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.24e-05 | 38 | 62 | 4 | M27757 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.85e-05 | 14 | 62 | 3 | MM15052 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.94e-05 | 82 | 62 | 5 | MM15922 | |
| Pathway | REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS | 3.55e-05 | 15 | 62 | 3 | M27766 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 6.28e-05 | 96 | 62 | 5 | M27784 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 9.88e-05 | 532 | 62 | 10 | M27870 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.72e-04 | 188 | 62 | 6 | MM15828 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.96e-04 | 26 | 62 | 3 | MM15502 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.20e-04 | 27 | 62 | 3 | MM15053 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | NCOR1 KMT2C TCF7 CITED4 EGFR TJP1 RPTOR GLI3 MAML1 SMURF1 ZNF227 TFAP2B SMURF2 TFAP2C NOTCH2 SMAD4 | 2.43e-04 | 1387 | 62 | 16 | M734 |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.45e-04 | 28 | 62 | 3 | M6177 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.45e-04 | 28 | 62 | 3 | M924 | |
| Pathway | REACTOME_GASTRULATION | 2.53e-04 | 129 | 62 | 5 | M46433 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 2.94e-04 | 73 | 62 | 4 | M638 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 3.34e-04 | 31 | 62 | 3 | M669 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 3.34e-04 | 31 | 62 | 3 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 3.34e-04 | 31 | 62 | 3 | MM14789 | |
| Pathway | WP_CANCER_PATHWAYS | 3.48e-04 | 507 | 62 | 9 | M48302 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 5.22e-04 | 36 | 62 | 3 | M39831 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 5.75e-04 | 87 | 62 | 4 | M39465 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS | 6.72e-04 | 9 | 62 | 2 | MM15509 | |
| Pathway | WP_EGFEGFR_SIGNALING | 7.19e-04 | 162 | 62 | 5 | M39334 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 7.69e-04 | 94 | 62 | 4 | M1041 | |
| Pathway | PID_BMP_PATHWAY | 8.23e-04 | 42 | 62 | 3 | M181 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS | 8.37e-04 | 10 | 62 | 2 | M27764 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 8.82e-04 | 43 | 62 | 3 | M39706 | |
| Pathway | WP_GENES_CONTROLLING_NEPHROGENESIS | 9.44e-04 | 44 | 62 | 3 | M39891 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | TYRP1 NCOR1 KMT2C ZSWIM8 TCF7 EGFR EGR2 MAML1 KAZN IRX1 TERT TFAP2B TFAP2C NCK2 SMAD4 | 1.10e-03 | 1432 | 62 | 15 | M509 |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.10e-03 | 178 | 62 | 5 | M2890 | |
| Pathway | PID_LKB1_PATHWAY | 1.14e-03 | 47 | 62 | 3 | M87 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.14e-03 | 47 | 62 | 3 | M646 | |
| Pathway | KEGG_ENDOCYTOSIS | 1.18e-03 | 181 | 62 | 5 | M1519 | |
| Pathway | WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION | 1.22e-03 | 12 | 62 | 2 | M39519 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.22e-03 | 12 | 62 | 2 | M27159 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.22e-03 | 12 | 62 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.22e-03 | 12 | 62 | 2 | M47533 | |
| Pathway | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | 1.44e-03 | 13 | 62 | 2 | MM15095 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.44e-03 | 13 | 62 | 2 | M47534 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 1.45e-03 | 51 | 62 | 3 | M665 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 1.67e-03 | 14 | 62 | 2 | M16884 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 1.67e-03 | 14 | 62 | 2 | MM1485 | |
| Pathway | PID_TGFBR_PATHWAY | 1.71e-03 | 54 | 62 | 3 | M286 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.71e-03 | 54 | 62 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.71e-03 | 54 | 62 | 3 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.81e-03 | 55 | 62 | 3 | M971 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.00e-03 | 57 | 62 | 3 | MM14713 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.00e-03 | 57 | 62 | 3 | MM15643 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.10e-03 | 58 | 62 | 3 | M2049 | |
| Pathway | BIOCARTA_EFP_PATHWAY | 2.20e-03 | 16 | 62 | 2 | M22011 | |
| Pathway | PID_NOTCH_PATHWAY | 2.21e-03 | 59 | 62 | 3 | M17 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.31e-03 | 418 | 62 | 7 | MM15587 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.43e-03 | 61 | 62 | 3 | M39540 | |
| Pathway | REACTOME_SPECIFICATION_OF_THE_NEURAL_PLATE_BORDER | 2.48e-03 | 17 | 62 | 2 | M48248 | |
| Pathway | BIOCARTA_TEL_PATHWAY | 2.48e-03 | 17 | 62 | 2 | MM1508 | |
| Pathway | REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION | 2.48e-03 | 17 | 62 | 2 | M45017 | |
| Pathway | BIOCARTA_TEL_PATHWAY | 2.48e-03 | 17 | 62 | 2 | M10401 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 COL18A1 KMT2C PHLDB1 TNRC18 SH3TC1 EGFR ACTR3C TJP1 NEIL1 NFIC BICRA RPTOR NUP210 TRPS1 SMURF1 CILK1 SHROOM2 SMURF2 GLIS1 NOTCH2 NCK2 | 6.40e-12 | 1489 | 85 | 22 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOR1 KMT2C PHLDB1 TNRC18 PLOD3 ARAP3 SH3TC1 BICRA RPTOR MAML1 LRRC56 LAMA5 STK11IP SMURF2 NOTCH2 ARHGAP33 NCK2 BAHCC1 | 1.54e-10 | 1105 | 85 | 18 | 35748872 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.54e-08 | 351 | 85 | 10 | 38297188 | |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 5.63e-08 | 4 | 85 | 3 | 12209837 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 12784250 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 5.63e-08 | 4 | 85 | 3 | 8245032 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 5.63e-08 | 4 | 85 | 3 | 7989379 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 5.63e-08 | 4 | 85 | 3 | 11152753 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 5.63e-08 | 4 | 85 | 3 | 36130203 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 5.63e-08 | 4 | 85 | 3 | 10434059 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 15101689 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 10577388 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 5.63e-08 | 4 | 85 | 3 | 8634322 | |
| Pubmed | HB-EGF regulates Prss56 expression during mouse decidualization via EGFR/ERK/EGR2 signaling pathway. | 5.63e-08 | 4 | 85 | 3 | 28611210 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 17938178 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 2.80e-07 | 6 | 85 | 3 | 12767889 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.11e-07 | 180 | 85 | 7 | 35198878 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TCF7 FOXD4L1 EGR2 EGR3 NFIC GLI3 TRPS1 IRX1 RFX4 TFAP2B TFAP2C GLIS1 SMAD4 | 3.14e-07 | 908 | 85 | 13 | 19274049 |
| Pubmed | CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. | 4.90e-07 | 7 | 85 | 3 | 14701756 | |
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 10951186 | ||
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 11744733 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 8.84e-07 | 544 | 85 | 10 | 28473536 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ZSWIM8 PHLDB1 HECW1 RALBP1 LAMA5 KAZN R3HDM1 ECM1 MEGF11 NOTCH2 | 1.15e-06 | 560 | 85 | 10 | 21653829 |
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 21531791 | ||
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 12504852 | ||
| Pubmed | NCOR1 ZNF106 PSG2 DROSHA SMURF1 LAMA5 CILK1 SMURF2 NOTCH2 SMAD4 | 1.86e-06 | 591 | 85 | 10 | 15231748 | |
| Pubmed | 2.84e-06 | 40 | 85 | 4 | 23362348 | ||
| Pubmed | ZSWIM8 SH3TC1 DROSHA BICRA RPTOR GLI3 PRSS56 TRPS1 HELZ ABCA8 NOTCH2 ARHGAP33 BAHCC1 | 3.10e-06 | 1116 | 85 | 13 | 31753913 | |
| Pubmed | NCOR1 PHLDB1 TCF7 AXL TRPS1 RGPD1 MAML1 ZNF227 ATP2B3 FHIP2B | 3.66e-06 | 638 | 85 | 10 | 31182584 | |
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 37300483 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 31899247 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23485457 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9837959 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8187550 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 33090007 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 31043587 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 1313367 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 1531651 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 27775700 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20215112 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22252018 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 36167651 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25690014 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28487311 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 34524458 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19074676 | ||
| Pubmed | Emerging roles of Egr2 and Egr3 in the control of systemic autoimmunity. | 5.90e-06 | 2 | 85 | 2 | 27856665 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23720781 | ||
| Pubmed | Regulation of EGFR protein stability by the HECT-type ubiquitin ligase SMURF2. | 5.90e-06 | 2 | 85 | 2 | 21750651 | |
| Pubmed | Coexpression of receptor tyrosine kinase AXL and EGFR in human primary lung adenocarcinomas. | 5.90e-06 | 2 | 85 | 2 | 26475093 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26018735 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24551047 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17699740 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 31953310 | ||
| Pubmed | EGR3 as a potential susceptibility gene for schizophrenia in Korea. | 5.90e-06 | 2 | 85 | 2 | 20687139 | |
| Pubmed | Egr-2 and Egr-3 are negative regulators of T cell activation. | 5.90e-06 | 2 | 85 | 2 | 15834410 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 29314730 | ||
| Pubmed | TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer. | 5.90e-06 | 2 | 85 | 2 | 26149460 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 32785770 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 30463991 | ||
| Pubmed | Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells. | 5.90e-06 | 2 | 85 | 2 | 15809071 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 33529121 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12708492 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 35218185 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25873175 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18927080 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19726746 | ||
| Pubmed | Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. | 5.90e-06 | 2 | 85 | 2 | 22751098 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23021953 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26766154 | ||
| Pubmed | Egr2 and 3 control inflammation, but maintain homeostasis, of PD-1high memory phenotype CD4 T cells. | 5.90e-06 | 2 | 85 | 2 | 32709717 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23921085 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17630431 | ||
| Pubmed | Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines. | 5.90e-06 | 2 | 85 | 2 | 16216224 | |
| Pubmed | Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells. | 5.90e-06 | 2 | 85 | 2 | 36342511 | |
| Pubmed | Human Melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C. | 5.90e-06 | 2 | 85 | 2 | 24023917 | |
| Pubmed | Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2. | 6.28e-06 | 15 | 85 | 3 | 19144635 | |
| Pubmed | Assembly and structure of Lys33-linked polyubiquitin reveals distinct conformations. | 7.71e-06 | 16 | 85 | 3 | 25723849 | |
| Pubmed | 7.71e-06 | 16 | 85 | 3 | 19733164 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 9.69e-06 | 424 | 85 | 8 | 21731673 | |
| Pubmed | Foxf1 haploinsufficiency reduces Notch-2 signaling during mouse lung development. | 1.12e-05 | 18 | 85 | 3 | 14607778 | |
| Pubmed | Primary cilia maintain corneal epithelial homeostasis by regulation of the Notch signaling pathway. | 1.33e-05 | 19 | 85 | 3 | 27122169 | |
| Pubmed | 1.33e-05 | 19 | 85 | 3 | 21572392 | ||
| Pubmed | 1.48e-05 | 214 | 85 | 6 | 22199357 | ||
| Pubmed | 1.52e-05 | 215 | 85 | 6 | 35973513 | ||
| Pubmed | Angiomotin regulates endothelial cell-cell junctions and cell motility. | 1.77e-05 | 3 | 85 | 2 | 16043488 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 38417636 | ||
| Pubmed | LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1. | 1.77e-05 | 3 | 85 | 2 | 11741830 | |
| Pubmed | The Smurf ubiquitin ligases regulate tissue separation via antagonistic interactions with ephrinB1. | 1.77e-05 | 3 | 85 | 2 | 23475958 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 17974918 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 22356909 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10777553 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 29222328 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 35045301 | ||
| Pubmed | Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes. | 1.77e-05 | 3 | 85 | 2 | 25964481 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 32319651 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 35864973 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 37537194 | ||
| Pubmed | T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. | 1.77e-05 | 3 | 85 | 2 | 22109558 | |
| Interaction | EGR2 interactions | 3.94e-08 | 171 | 84 | 9 | int:EGR2 | |
| Interaction | CYP2B6 interactions | 3.85e-06 | 8 | 84 | 3 | int:CYP2B6 | |
| Interaction | TOP3B interactions | NCOR1 KMT2C PHLDB1 TNRC18 PLOD3 ARAP3 SH3TC1 BICRA RPTOR MAML1 LRRC56 LAMA5 HELZ STK11IP SMURF2 NOTCH2 ARHGAP33 NCK2 BAHCC1 | 7.54e-06 | 1470 | 84 | 19 | int:TOP3B |
| Interaction | ATN1 interactions | 1.31e-05 | 187 | 84 | 7 | int:ATN1 | |
| Interaction | C17orf78 interactions | 1.50e-05 | 12 | 84 | 3 | int:C17orf78 | |
| Interaction | HCRTR2 interactions | 2.07e-05 | 39 | 84 | 4 | int:HCRTR2 | |
| Interaction | SOX7 interactions | 2.37e-05 | 82 | 84 | 5 | int:SOX7 | |
| Interaction | HSD17B6 interactions | 3.07e-05 | 15 | 84 | 3 | int:HSD17B6 | |
| Interaction | GSC interactions | 3.15e-05 | 87 | 84 | 5 | int:GSC | |
| Interaction | PSG2 interactions | 5.14e-05 | 3 | 84 | 2 | int:PSG2 | |
| Interaction | LAIR2 interactions | 5.16e-05 | 49 | 84 | 4 | int:LAIR2 | |
| Interaction | SOX3 interactions | 5.45e-05 | 18 | 84 | 3 | int:SOX3 | |
| Interaction | SMG7 interactions | 5.54e-05 | 319 | 84 | 8 | int:SMG7 | |
| Interaction | DTX2 interactions | 7.02e-05 | 330 | 84 | 8 | int:DTX2 | |
| Interaction | CITED4 interactions | 8.80e-05 | 21 | 84 | 3 | int:CITED4 | |
| Interaction | NOTCH4 interactions | 8.80e-05 | 21 | 84 | 3 | int:NOTCH4 | |
| Interaction | CRX interactions | 9.22e-05 | 254 | 84 | 7 | int:CRX | |
| Interaction | TEAD1 interactions | 9.42e-05 | 176 | 84 | 6 | int:TEAD1 | |
| Interaction | SMARCA2 interactions | 9.76e-05 | 346 | 84 | 8 | int:SMARCA2 | |
| Interaction | PAX8 interactions | 1.01e-04 | 111 | 84 | 5 | int:PAX8 | |
| Interaction | IL1RAPL2 interactions | 1.02e-04 | 4 | 84 | 2 | int:IL1RAPL2 | |
| Interaction | LDLRAD4 interactions | 1.07e-04 | 59 | 84 | 4 | int:LDLRAD4 | |
| Interaction | TBR1 interactions | 1.10e-04 | 113 | 84 | 5 | int:TBR1 | |
| Interaction | TFAP2A interactions | 1.15e-04 | 114 | 84 | 5 | int:TFAP2A | |
| Interaction | TBXT interactions | 1.24e-04 | 116 | 84 | 5 | int:TBXT | |
| Interaction | NFIA interactions | 1.35e-04 | 188 | 84 | 6 | int:NFIA | |
| Interaction | ARHGAP5 interactions | 1.39e-04 | 63 | 84 | 4 | int:ARHGAP5 | |
| Interaction | RASD2 interactions | 1.50e-04 | 25 | 84 | 3 | int:RASD2 | |
| Interaction | KLF5 interactions | 1.65e-04 | 195 | 84 | 6 | int:KLF5 | |
| Interaction | TNK2 interactions | 1.65e-04 | 195 | 84 | 6 | int:TNK2 | |
| Interaction | PAX7 interactions | 1.70e-04 | 124 | 84 | 5 | int:PAX7 | |
| Interaction | ING2 interactions | 1.87e-04 | 68 | 84 | 4 | int:ING2 | |
| Interaction | CREBBP interactions | 1.91e-04 | 599 | 84 | 10 | int:CREBBP | |
| Interaction | FEV interactions | 2.05e-04 | 203 | 84 | 6 | int:FEV | |
| Interaction | LILRB4 interactions | 2.12e-04 | 28 | 84 | 3 | int:LILRB4 | |
| Interaction | TEAD2 interactions | 2.12e-04 | 130 | 84 | 5 | int:TEAD2 | |
| Interaction | PAX9 interactions | 2.12e-04 | 130 | 84 | 5 | int:PAX9 | |
| Interaction | OCLN interactions | 2.34e-04 | 500 | 84 | 9 | int:OCLN | |
| Interaction | FBXL15 interactions | 2.36e-04 | 29 | 84 | 3 | int:FBXL15 | |
| Interaction | NFIC interactions | 2.46e-04 | 210 | 84 | 6 | int:NFIC | |
| Interaction | FBXO2 interactions | 3.15e-04 | 411 | 84 | 8 | int:FBXO2 | |
| Interaction | NFIB interactions | 3.20e-04 | 142 | 84 | 5 | int:NFIB | |
| Interaction | TRPS1 interactions | 3.30e-04 | 143 | 84 | 5 | int:TRPS1 | |
| Interaction | ERG interactions | 3.40e-04 | 223 | 84 | 6 | int:ERG | |
| Interaction | GPS2 interactions | 3.41e-04 | 144 | 84 | 5 | int:GPS2 | |
| Interaction | LRATD2 interactions | 3.48e-04 | 33 | 84 | 3 | int:LRATD2 | |
| Interaction | CD248 interactions | 3.56e-04 | 7 | 84 | 2 | int:CD248 | |
| Interaction | CD300LB interactions | 3.56e-04 | 7 | 84 | 2 | int:CD300LB | |
| Interaction | NFIX interactions | 3.74e-04 | 227 | 84 | 6 | int:NFIX | |
| Interaction | UBE2I interactions | NCOR1 ZNF106 EGFR EGR2 NUP210 TRPS1 TFAP2B SMURF2 TFAP2C SMAD4 | 3.84e-04 | 654 | 84 | 10 | int:UBE2I |
| GeneFamily | ATPases Ca2+ transporting | 1.76e-06 | 9 | 51 | 3 | 1209 | |
| GeneFamily | Aquaporins | 6.95e-04 | 14 | 51 | 2 | 305 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.25e-03 | 25 | 51 | 2 | 775 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 2.43e-03 | 26 | 51 | 2 | 904 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.83e-03 | 718 | 51 | 7 | 28 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.62e-03 | 36 | 51 | 2 | 823 | |
| GeneFamily | PDZ domain containing | 9.03e-03 | 152 | 51 | 3 | 1220 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.09e-02 | 163 | 51 | 3 | 590 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | PHLDB1 KCNA1 FOXD4L1 EGR2 IL1RAPL2 EGR3 NFIC ACAN SLITRK5 OTOP3 IRX1 TFAP2C MEGF11 NOTCH2 | 5.71e-06 | 1035 | 85 | 14 | M9898 |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_MELANOMA | 6.99e-06 | 38 | 85 | 4 | M47982 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 1.28e-05 | 439 | 85 | 9 | M39054 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 2.86e-05 | 182 | 85 | 6 | MM993 | |
| Coexpression | GSE14308_TH17_VS_NATURAL_TREG_DN | 4.85e-05 | 200 | 85 | 6 | M3390 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 2.07e-05 | 143 | 83 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_plasmid-Confounder_removed-fold2.0_adjp0.05 | 5.00e-05 | 102 | 83 | 5 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-plasmid_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | MAGI1 PTK2B EGR2 AXL GLI3 TRPS1 PDGFC ECM1 ATP2B3 ATP2B4 ABCA8 NOTCH2 | 8.58e-05 | 827 | 83 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 9.82e-05 | 189 | 83 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO fibroblast-Confounder_removed-fold2.0_adjp0.05 | 1.00e-04 | 118 | 83 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO fibroblast_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 1.24e-04 | 284 | 83 | 7 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_500 | 1.35e-04 | 495 | 83 | 9 | PCBC_ratio_ECTO_vs_SC_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 1.41e-04 | 498 | 83 | 9 | PCBC_ratio_EB_vs_SC_500 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 9.24e-08 | 194 | 85 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.24e-08 | 194 | 85 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.69e-06 | 189 | 85 | 6 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.69e-06 | 189 | 85 | 6 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.85e-06 | 192 | 85 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.90e-06 | 193 | 85 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.96e-06 | 194 | 85 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 1.96e-06 | 194 | 85 | 6 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | Posterior_cortex-Endothelial|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.02e-06 | 195 | 85 | 6 | 988e3449691cc228cb55e5e30355136c97b12262 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col18a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.55e-06 | 148 | 85 | 5 | fc80c02b51cf55a04ce550838ee2f41d8f656f41 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.35e-05 | 159 | 85 | 5 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 162 | 85 | 5 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 162 | 85 | 5 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 162 | 85 | 5 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 162 | 85 | 5 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-05 | 169 | 85 | 5 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-05 | 169 | 85 | 5 | 0867528101767fc65e93b3561480bf830c50368d | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.81e-05 | 169 | 85 | 5 | 50cc0f5a022b95986949db63208a627cef9f4a69 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-05 | 172 | 85 | 5 | 1bad7b19724e1b53ace7e05644215334c9f43910 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 176 | 85 | 5 | 33323c97afe509147956b8df9f92ca6b0537e604 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4-Gpr17_(Bmp4)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.24e-05 | 86 | 85 | 4 | eb2b9e98ff97371f497ee1709848a2caaa46ed3d | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4-Gpr17_(Bmp4)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.24e-05 | 86 | 85 | 4 | 02ea5219e2faded2b50b96d41861e4f8a558e4e3 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-05 | 177 | 85 | 5 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-05 | 177 | 85 | 5 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 179 | 85 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 2.59e-05 | 182 | 85 | 5 | a5fd392178c2f533e265d2e3ce63b90c2553e4c1 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.59e-05 | 182 | 85 | 5 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 2.73e-05 | 184 | 85 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.80e-05 | 185 | 85 | 5 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| ToppCell | wk_08-11-Epithelial-PNS-COL20A1+_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.80e-05 | 185 | 85 | 5 | abec2a49fe0f0fa4cba49347207a1ee317333657 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 2.95e-05 | 187 | 85 | 5 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.95e-05 | 187 | 85 | 5 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.10e-05 | 189 | 85 | 5 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.10e-05 | 189 | 85 | 5 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-05 | 191 | 85 | 5 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-05 | 191 | 85 | 5 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | Hippocampus-Endothelial|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.34e-05 | 192 | 85 | 5 | 36deadab892d3e639a71f33697bb2d3cbbaa5372 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.51e-05 | 194 | 85 | 5 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 3.51e-05 | 194 | 85 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Lims2-Tmsb4x_(Lims2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.60e-05 | 97 | 85 | 4 | 2b69f41f0aca06da6705376bb6f530ee0e9ac737 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Lims2-Tmsb4x_(Lims2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.60e-05 | 97 | 85 | 4 | 75485ac0dca0dd6a01fe0abf679b984529d46c79 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.60e-05 | 195 | 85 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.60e-05 | 195 | 85 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.60e-05 | 195 | 85 | 5 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.60e-05 | 195 | 85 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.69e-05 | 196 | 85 | 5 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 3.78e-05 | 197 | 85 | 5 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 197 | 85 | 5 | b7aff83c27606d87565382a768119a863fe1c294 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 3.78e-05 | 197 | 85 | 5 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.87e-05 | 198 | 85 | 5 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.87e-05 | 198 | 85 | 5 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.87e-05 | 198 | 85 | 5 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.87e-05 | 198 | 85 | 5 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.96e-05 | 199 | 85 | 5 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.96e-05 | 199 | 85 | 5 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.06e-05 | 200 | 85 | 5 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-05 | 200 | 85 | 5 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-05 | 200 | 85 | 5 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-05 | 200 | 85 | 5 | d9dab2aed11e45c60d11ff0c5af1f2fbb9cb45d8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-05 | 200 | 85 | 5 | 33b7af6c50e65dc1bdf429572574ed072f8bc29f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-05 | 200 | 85 | 5 | 0655328373d1b58828e141ddb0dcbb2cce10dc50 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.06e-05 | 200 | 85 | 5 | ed4a41cb6782541d8fc928aaa12cf03bc1c630a2 | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.06e-05 | 200 | 85 | 5 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.06e-05 | 200 | 85 | 5 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-04 | 133 | 85 | 4 | 63d2f096ae47d9b587acc6c5fbd346e5e58842b8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 147 | 85 | 4 | f5109e0f4e8b46a977a763c9c72a2df9840e3977 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 147 | 85 | 4 | ad0c575bc9c5f201f2a7810452e8b3f741e65d89 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|World / Disease group and Cell class | 1.90e-04 | 149 | 85 | 4 | ce6552063510aa3e0b9d6e5b531eea67410e7056 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.10e-04 | 153 | 85 | 4 | 61fe71e32fc9c8cad875bc087aad0b0ff680bf45 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 154 | 85 | 4 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-04 | 157 | 85 | 4 | ffb8dd381e6b9adc5283fb49586e8bd63773c8d6 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-04 | 157 | 85 | 4 | c488ab1d6c6c7e5c2f4426805d1366b44711a031 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class | 2.32e-04 | 157 | 85 | 4 | 287bdc4e455cd0160261a93d13538e0def49fcd4 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-04 | 158 | 85 | 4 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 158 | 85 | 4 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-04 | 158 | 85 | 4 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-04 | 158 | 85 | 4 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-04 | 158 | 85 | 4 | 6811dc4f101dfa9a9cc13d949760d43aa522bf3b | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 158 | 85 | 4 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-04 | 162 | 85 | 4 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.68e-04 | 163 | 85 | 4 | 240d9f0ea45e8b2c7173e7674fd740555810f9e7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.68e-04 | 163 | 85 | 4 | a6e272e043859858084b8d4d96fa4ff9e6eca454 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 166 | 85 | 4 | aa2df07eff323ded751ced8938af08223d7f2029 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 166 | 85 | 4 | 695298a94d62b8adab083900003ec636fbaae5d9 | |
| ToppCell | Tuft-tuft-1|World / Class top | 3.00e-04 | 168 | 85 | 4 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.00e-04 | 168 | 85 | 4 | 9930bd63b60c03f0152838a79eef77da1c2dd8e5 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.00e-04 | 168 | 85 | 4 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.07e-04 | 169 | 85 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.07e-04 | 169 | 85 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-04 | 169 | 85 | 4 | 8f397cf4f9fd7c6fa88d01a95289ce2a6bc6938d | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 3.14e-04 | 170 | 85 | 4 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.14e-04 | 170 | 85 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.21e-04 | 171 | 85 | 4 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.21e-04 | 171 | 85 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.21e-04 | 171 | 85 | 4 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.28e-04 | 172 | 85 | 4 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 173 | 85 | 4 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| Drug | lanthanum | 7.78e-07 | 136 | 85 | 7 | CID000023926 | |
| Drug | AC1L1C2F | 3.56e-06 | 110 | 85 | 6 | CID000001711 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 4.69e-06 | 178 | 85 | 7 | 6193_DN | |
| Drug | 1sqc | 5.91e-06 | 10 | 85 | 3 | CID000444279 | |
| Drug | 2,5-dimethylquinone | 8.11e-06 | 11 | 85 | 3 | CID000008718 | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.24e-06 | 194 | 85 | 7 | 6933_DN | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 8.24e-06 | 194 | 85 | 7 | 3509_DN | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; PC3; HT_HG-U133A | 8.81e-06 | 196 | 85 | 7 | 4491_DN | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 9.41e-06 | 198 | 85 | 7 | 2118_UP | |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | 9.41e-06 | 198 | 85 | 7 | 7375_UP | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 9.41e-06 | 198 | 85 | 7 | 5334_DN | |
| Drug | arachidonic acid sodium salt; Up 200; 10uM; MCF7; HG-U133A | 9.41e-06 | 198 | 85 | 7 | 443_UP | |
| Drug | Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; PC3; HT_HG-U133A | 9.73e-06 | 199 | 85 | 7 | 6672_DN | |
| Drug | 1vyq | 1.08e-05 | 12 | 85 | 3 | CID004369390 | |
| Drug | Ro 46861 | 1.08e-05 | 12 | 85 | 3 | CID000003128 | |
| Drug | 8-hydroxycoumarin | 1.40e-05 | 13 | 85 | 3 | CID000122783 | |
| Drug | verapamil | PTK2B KCNA1 EGFR RALBP1 RPTOR CILK1 ATP2B2 ATP2B3 ATP2B4 ABCA8 | 1.44e-05 | 490 | 85 | 10 | CID000002520 |
| Drug | p-hydroxyhippuric acid | 1.77e-05 | 14 | 85 | 3 | CID000151012 | |
| Drug | linopirdine | 2.00e-05 | 43 | 85 | 4 | CID000003932 | |
| Drug | AC1L88YH | 3.29e-05 | 17 | 85 | 3 | CID000374551 | |
| Drug | Sp 1 (pharmaceutical) | 3.73e-05 | 548 | 85 | 10 | CID000099040 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.33e-05 | 177 | 85 | 6 | 4652_DN | |
| Drug | copper(II) chloride | 5.47e-05 | 20 | 85 | 3 | CID000169664 | |
| Drug | 2brh | 6.36e-05 | 21 | 85 | 3 | CID000848641 | |
| Drug | Parthenolide [20554-84-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 6.42e-05 | 183 | 85 | 6 | 5530_DN | |
| Drug | B-Ms | 6.87e-05 | 114 | 85 | 5 | CID000445091 | |
| Drug | estradiol-17 beta-glucuronide | 7.35e-05 | 22 | 85 | 3 | ctd:C025483 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 7.67e-05 | 189 | 85 | 6 | 5208_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 8.37e-05 | 192 | 85 | 6 | 5238_UP | |
| Drug | AC1L25Y6 | 8.43e-05 | 23 | 85 | 3 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 8.43e-05 | 23 | 85 | 3 | CID000165791 | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 8.86e-05 | 194 | 85 | 6 | 3859_DN | |
| Drug | Brinzolamide [138890-62-7]; Down 200; 10.4uM; PC3; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 6670_DN | |
| Drug | Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 6808_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 6926_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 3327_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 5052_UP | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 3404_DN | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; HL60; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 2541_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; HL60; HG-U133A | 9.64e-05 | 197 | 85 | 6 | 2022_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; HL60; HG-U133A | 9.91e-05 | 198 | 85 | 6 | 1588_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 1648_UP | |
| Drug | Oxybenzone [131-57-7]; Up 200; 17.6uM; PC3; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 6309_UP | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; PC3; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 7310_DN | |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 7127_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 6001_DN | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 7146_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 3707_UP | |
| Drug | Rifampicin [13292-46-1]; Up 200; 4.8uM; PC3; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 4008_UP | |
| Drug | Nimodipine [66085-59-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 6480_DN | |
| Drug | Reserpine [50-55-5]; Up 200; 6.6uM; HL60; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 3003_UP | |
| Drug | Rimexolone [49697-38-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 5517_DN | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; PC3; HT_HG-U133A | 1.05e-04 | 200 | 85 | 6 | 5730_UP | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.05e-04 | 200 | 85 | 6 | 3483_UP | |
| Drug | bisindolylmaleimide | 1.09e-04 | 25 | 85 | 3 | ctd:C088060 | |
| Drug | cyhexatin | 1.09e-04 | 25 | 85 | 3 | CID005364545 | |
| Drug | phosphotyrosine (pY | 1.14e-04 | 203 | 85 | 6 | CID000030819 | |
| Drug | dodecyl ether | 1.23e-04 | 26 | 85 | 3 | CID000020667 | |
| Drug | C13932 | 1.23e-04 | 206 | 85 | 6 | CID000168297 | |
| Drug | tBuBHQ | 1.30e-04 | 69 | 85 | 4 | CID000002374 | |
| Drug | 3-quinolinecarbonitrile | 1.37e-04 | 5 | 85 | 2 | CID000093177 | |
| Drug | iodixanol | 1.71e-04 | 29 | 85 | 3 | CID000003724 | |
| Drug | octaethylene glycol | 1.71e-04 | 29 | 85 | 3 | CID000078798 | |
| Drug | NSC618487 | PTK2B KCNA1 EGFR TJP1 AXL NFIC ACAN MAML1 PLD2 ATP2B2 ATP2B3 ATP2B4 | 1.75e-04 | 933 | 85 | 12 | CID000005279 |
| Drug | Go 6976 | 1.80e-04 | 75 | 85 | 4 | ctd:C081021 | |
| Drug | SCH 49210 | 2.05e-04 | 6 | 85 | 2 | CID000158548 | |
| Drug | x MC | 2.09e-04 | 31 | 85 | 3 | CID000017563 | |
| Drug | rosavin | 2.30e-04 | 32 | 85 | 3 | ctd:C529148 | |
| Drug | pomiferin | 2.53e-04 | 33 | 85 | 3 | ctd:C474837 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 4.11e-07 | 6 | 82 | 3 | DOID:0050429 (implicated_via_orthology) | |
| Disease | nevus count, cutaneous melanoma | 5.65e-06 | 91 | 82 | 5 | EFO_0000389, EFO_0004632 | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.78e-05 | 293 | 82 | 7 | C1708349 | |
| Disease | Stomach Neoplasms | 1.95e-05 | 297 | 82 | 7 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 2.07e-05 | 300 | 82 | 7 | C0024623 | |
| Disease | glioma | 3.07e-05 | 22 | 82 | 3 | EFO_0005543 | |
| Disease | Intrahepatic Cholangiocarcinoma | 4.01e-05 | 24 | 82 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 4.01e-05 | 24 | 82 | 3 | C3805278 | |
| Disease | Bladder Neoplasm | 4.55e-05 | 140 | 82 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 4.71e-05 | 141 | 82 | 5 | C0005684 | |
| Disease | Cholangiocarcinoma | 5.14e-05 | 26 | 82 | 3 | C0206698 | |
| Disease | Disproportionate short stature | 6.42e-05 | 77 | 82 | 4 | C0878659 | |
| Disease | central nervous system cancer, glioma | 7.17e-05 | 29 | 82 | 3 | EFO_0000326, EFO_0005543 | |
| Disease | central nervous system cancer | 8.79e-05 | 31 | 82 | 3 | EFO_0000326 | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 9.68e-05 | 32 | 82 | 3 | EFO_0021870 | |
| Disease | cervical cancer | 1.16e-04 | 34 | 82 | 3 | C4048328 | |
| Disease | Uterine Cervical Neoplasm | 1.27e-04 | 35 | 82 | 3 | C0007873 | |
| Disease | brain measurement, neuroimaging measurement | 1.47e-04 | 550 | 82 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Pancreatic Neoplasm | 1.77e-04 | 100 | 82 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 1.91e-04 | 102 | 82 | 4 | C0346647 | |
| Disease | age at onset, glioblastoma multiforme | 2.11e-04 | 8 | 82 | 2 | EFO_0000519, EFO_0004847 | |
| Disease | Glioblastoma Multiforme | 2.65e-04 | 111 | 82 | 4 | C1621958 | |
| Disease | Liver Diseases, Parasitic | 2.71e-04 | 9 | 82 | 2 | C0023897 | |
| Disease | glioblastoma multiforme | 2.71e-04 | 9 | 82 | 2 | EFO_0000519 | |
| Disease | myopathy (implicated_via_orthology) | 3.27e-04 | 48 | 82 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 3.48e-04 | 49 | 82 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | sleep disorder (implicated_via_orthology) | 4.13e-04 | 11 | 82 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.38e-04 | 53 | 82 | 3 | C4707243 | |
| Disease | renal cell carcinoma (is_marker_for) | 4.55e-04 | 128 | 82 | 4 | DOID:4450 (is_marker_for) | |
| Disease | peptic esophagitis (biomarker_via_orthology) | 4.94e-04 | 12 | 82 | 2 | DOID:13976 (biomarker_via_orthology) | |
| Disease | S-6-hydroxywarfarin measurement | 5.70e-04 | 368 | 82 | 6 | EFO_0803326 | |
| Disease | central nervous system cancer, glioblastoma multiforme | 6.79e-04 | 14 | 82 | 2 | EFO_0000326, EFO_0000519 | |
| Disease | Myopia | 7.21e-04 | 385 | 82 | 6 | HP_0000545 | |
| Disease | transitional cell carcinoma (is_marker_for) | 7.28e-04 | 63 | 82 | 3 | DOID:2671 (is_marker_for) | |
| Disease | neuroimaging measurement | MAGI1 NCOR1 COL18A1 ZNF106 EGFR GLI3 TRPS1 RGPD1 PDGFC BAHCC1 | 7.52e-04 | 1069 | 82 | 10 | EFO_0004346 |
| Disease | digit length ratio | 8.93e-04 | 16 | 82 | 2 | EFO_0004841 | |
| Disease | Craniofacial Abnormalities | 9.54e-04 | 156 | 82 | 4 | C0376634 | |
| Disease | prostate cancer (is_marker_for) | 9.54e-04 | 156 | 82 | 4 | DOID:10283 (is_marker_for) | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 1.01e-03 | 17 | 82 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | Adrenocortical carcinoma | 1.13e-03 | 18 | 82 | 2 | C0206686 | |
| Disease | cortical surface area measurement | MAGI1 NCOR1 ZNF106 EGFR TJP1 RALBP1 GLI3 RGPD1 PDGFC RFX4 TFAP2B | 1.22e-03 | 1345 | 82 | 11 | EFO_0010736 |
| Disease | Glioblastoma | 1.40e-03 | 79 | 82 | 3 | C0017636 | |
| Disease | cytotoxicity measurement, response to metformin | 1.55e-03 | 21 | 82 | 2 | EFO_0006952, GO_1901558 | |
| Disease | Giant Cell Glioblastoma | 1.68e-03 | 84 | 82 | 3 | C0334588 | |
| Disease | urate measurement, bone density | 1.69e-03 | 619 | 82 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | Glioma | 1.85e-03 | 87 | 82 | 3 | C0017638 | |
| Disease | facial morphology measurement | 1.91e-03 | 466 | 82 | 6 | EFO_0007841 | |
| Disease | vasculitis | 2.02e-03 | 24 | 82 | 2 | EFO_0006803 | |
| Disease | breast carcinoma | 2.07e-03 | 1019 | 82 | 9 | EFO_0000305 | |
| Disease | Squamous cell carcinoma of esophagus | 2.38e-03 | 95 | 82 | 3 | C0279626 | |
| Disease | hip circumference | 2.54e-03 | 338 | 82 | 5 | EFO_0005093 | |
| Disease | Nephrotic Syndrome | 2.56e-03 | 27 | 82 | 2 | C0027726 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 2.56e-03 | 27 | 82 | 2 | DOID:8552 (is_marker_for) | |
| Disease | eosinophil count | PTK2B TCF7 EGR2 NFIC SMURF1 TERT TFAP2B NOTCH2 NCK2 SMAD4 BAHCC1 | 2.69e-03 | 1488 | 82 | 11 | EFO_0004842 |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 2.75e-03 | 28 | 82 | 2 | DOID:3083 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYGLGHPALHQNLPP | 836 | Q9P281 | |
| SHMQHPGQLPVYSRP | 911 | Q9P281 | |
| GLFRKPHPQYPDHSQ | 601 | Q8WWN8 | |
| LHLRHSPPAYSGPAV | 166 | Q8IXF9 | |
| HLSSAGQHLYSPAPP | 31 | Q92754 | |
| GQHLYSPAPPLSHTG | 36 | Q92754 | |
| LHLRHSPPAYSGPAV | 166 | A6NM10 | |
| SGRNAPLHSPPSEHY | 981 | Q01814 | |
| GRNAPLHSPPSEHYT | 956 | Q16720 | |
| SGRKAPLHSPPSQHY | 946 | P23634 | |
| DPYSLNPLHQPQQHP | 91 | Q92481 | |
| PVPSVHYNSHLNQPL | 661 | Q15032 | |
| LYRTGEPSPPHDILH | 41 | Q15311 | |
| NPNSPPTGIPLRHYD | 421 | Q9H8K7 | |
| YPALPHDTAISGPLH | 621 | Q33E94 | |
| AAAAYNPHHLPLRPI | 306 | P11161 | |
| GSIHSPRFPHTYPRN | 56 | Q9NRA1 | |
| AALTPRASPGHSPHY | 1841 | Q8TEM1 | |
| YRPDEQPSLRPHHDS | 656 | O60568 | |
| YLQPSHVNLLSHQPP | 481 | Q92585 | |
| GHLQGEHPYLTPSPE | 2406 | Q04721 | |
| RPHAVLYQDPHAGPL | 146 | Q7RTS5 | |
| PRNSHIPGHYDLLPV | 1016 | A6BM72 | |
| HGSLPHVAEPSVPYR | 91 | P10071 | |
| QTLYHSHPPHPADRQ | 291 | Q674X7 | |
| PGHPQDGSYPRQADH | 16 | Q09470 | |
| NQRHSDPYAHPPGTP | 2196 | Q8NEZ4 | |
| RQHPSLESSYPPDLH | 1266 | Q96QZ7 | |
| HAHLRFYTAPPGPRL | 96 | Q96FI4 | |
| LHPAHAPQISYTGPS | 261 | O43639 | |
| VSQLPSLRPEHHHYP | 811 | Q76N89 | |
| QIPLSYPQGHGFHPL | 191 | Q9C0K3 | |
| HVETRPLYHPHSPGL | 1446 | A9Z1Z3 | |
| PLYHPHSPGLLQGSL | 1451 | A9Z1Z3 | |
| NSSRPPGHIVYPKHQ | 11 | Q9NRY7 | |
| RQPEAPGDNPHTLYA | 421 | Q86V87 | |
| KNSHIPGHYDLPPVR | 1011 | Q5VY43 | |
| RAHKPSYHPIPQENT | 371 | Q6P3R8 | |
| QLHDSNPYPRREHPH | 1511 | P39060 | |
| GFYRSPNHPLDSPHV | 411 | O15230 | |
| LPAPHAQYAIPNRHF | 1346 | P42694 | |
| YPNQTGLPDPLSRHH | 656 | P16112 | |
| PPDHLGYSAPQHPAR | 1146 | O14559 | |
| HNQPLNPAPSRDPHY | 1111 | P00533 | |
| YPNRPSKTPLHERPH | 261 | Q06889 | |
| NTAPGRRPYALLHPH | 251 | Q9NU39 | |
| QPHYQLRACPSHQPD | 276 | Q16610 | |
| YPSPVNSLHTPPLHR | 756 | Q14289 | |
| NPLRPNGYHSLSTPL | 551 | Q8NBF1 | |
| ILTPYPGPRLHHSQS | 531 | Q8TE68 | |
| LQQAPGRTPAPSYPH | 1511 | Q9NZM4 | |
| GPNRLPSFNYPSDHL | 401 | Q9UK39 | |
| FAHGHPLYTRLPPSA | 16 | P0CW18 | |
| NSHHSSYQPLCLPLP | 496 | P0DJD0 | |
| LHHPKPQNPFYLETG | 866 | A6NKG5 | |
| LQYRSHLEPSGNPLP | 431 | Q8N1F8 | |
| ANNSSSPHFRHLPPY | 196 | Q9NRR4 | |
| NHLPRNSPQYHQPDL | 1116 | A2VDJ0 | |
| HGVRPLPYRHPESQQ | 391 | Q8IYG6 | |
| PVPSLGNHHTYCNLP | 631 | Q9NP60 | |
| PLQHPAFLPSHGLYT | 351 | P78414 | |
| EGPLHHYRPQQESPS | 2011 | O75376 | |
| SRTAPYTPNLPHHQN | 271 | Q13485 | |
| QSPHSGRHPPLYSDH | 421 | Q13796 | |
| PQPHSLPAQTSHYLR | 756 | Q8TE82 | |
| HTAIRYPPHLNPQDP | 391 | P08651 | |
| PHRHQKTPENYPNAG | 406 | P00747 | |
| PAGAQYTPHSHQFPR | 911 | Q8N122 | |
| NRPHGHQSPELPEGY | 226 | Q9HCE7 | |
| SPHLYFLAPGQQPHD | 896 | O94911 | |
| AAAHGPHALRTLPPY | 21 | Q96RK1 | |
| RQHQASQPPLHLTYP | 336 | Q9UPZ9 | |
| HLHTPPDLPEGYEQR | 246 | Q9HAU4 | |
| YPPGRSPLHHAQQLQ | 886 | O15417 | |
| HYLSHVPGLPNPCQN | 1126 | Q9UHF7 | |
| DSRPHSPQYPHDGRD | 71 | P17643 | |
| PNYDLRRPHQYLHPG | 891 | O94991 | |
| PHQLRLGSLHPHTPY | 291 | P30530 | |
| SYHLALQPPQSRPSG | 291 | Q86UU1 | |
| NQPPHGVPQLSLYEH | 151 | P36402 | |
| HPGHRPDKEPNLTYE | 1026 | Q07157 | |
| HSPGLHPYTALQPHL | 1501 | A7E2V4 | |
| YSPRLPLHPNVHTGE | 261 | Q86WZ6 | |
| LHGPDLPRIHPSYTN | 236 | P11465 | |
| PPITPRYSHTAHVLN | 581 | O60294 | |
| SLEPGYSHPFPARHL | 141 | Q99990 | |
| HRHDSYAPPRPGTLA | 321 | O14939 | |
| SYSQPAWHHRGPPQR | 116 | Q9H2Y7 | |
| YQLGAATQARPPPHA | 176 | O14746 |